Publications


CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.

Use the search link below to find specific articles, or articles by year, author, trial or group, back to 2005.

Search for articles

2016

Abed H S, Chen V, Kilborn M J, Sy R W Periprocedural management of novel oral anticoagulants during atrial fibrillation ablation: controversies and review of the current evidence. Heart Lung and Circulation 2016;  25 (12): 1164–1176.

Abed H S, Fulcher J, Kilborn M J, Keech A C Inappropriate sinus tachycardia: focus on ivabradine. Internal Medicine Journal 2016;  46 (8): 875–883.

Agar M, Koh ES, Gibbs E, Barnes EH, Hovey E, Livingstone A, Sawkins K, Chye R, Lovell MR, Clark K, Vardy J, King M Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire-Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer 2016;  24 (3): 1–10.

Al Muderis M, Khemka A, Lord S J, Van de Meent H, Frolke J P Safety of osseointegrated implants for transfemoral amputees: a two-center prospective cohort study. Journal of Bone and Joint Surgery. American Volume 2016;  98 (11): 900–909.

Al-Rubaie Z, Askie L M, Ray J G, Hudson H M, Lord S J The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. BJOG: International Journal of Obstetrics and Gynaecology 2016;  123 (9): 1441–1452.

Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, Simes J, Tonkin AM, Sullivan DR, Barnes EH, Nestel PJ, Kingwell BA, Marre M, Neal B, Poulter NR, Rodgers A, Williams B, Zoungas S, Hillis GS, Chalmers J, Woodward M, Meikle PJ Plasma lipidomic profiles improve upon traditional risk factors for the prediction of cardiovascular events in type 2 diabetes. Circulation 2016;

Askie L Trial registration records, updates, and protocols. Lancet 2016;  388 (10042): 341-342.

Bahin F F, Rasouli K N, Byth K, Hourigan L F, Singh R, Brown G J, Zanati S A, Moss A, Raftopoulos S, Williams S J, Bourke M J Prediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: A clinical risk score. American Journal of Gastroenterology 2016;  111 (8): 1115–1122.

Barton K, Hiener B, Winckelmann A, Rasmussen T A, Shao W, Byth K, Lanfear R, Solomon A, McMahon J, Harrington S, Buzon M, Lichterfeld M, Denton P W, Olesen R, Ostergaard L, Tolstrup M, Lewin S R, Sogaard O S, Palmer S Broad activation of latent HIV-1 in vivo. Nature Communications 2016;  7: 12731.

Bartsch E, Medcalf K E, Park A L, Ray J G, Al-Rubaie Z T A, Askie L M, Berger H, Blake J, Graves L, Kingdom J C, Lebovic G, Lord S J, Maguire J L, Mamdani M M, Meloche J, Urquia M L, Van Wagner V Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ (Online) 2016;  353: i1753. Full text

Basu A, Jenkins A J, Zhang Y, Stoner J A, Klein R L, Lopes-Virella M F, Garvey W T, Lyons T J Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis 2016;  244: 93–100.

Basu A, Jenkins A J, Zhang Y, Stoner J A, Klein R L, Lopes-Virella M F, Timothy Garvey W, Lyons T J Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Data in Brief 2016;  6: 33–38. Full text

Bekendam R H, Bendapudi P K, Lin L, Nag P P, Pu J, Kennedy D R, Feldenzer A, Chiu J, Cook K M, Furie B, Huang M, Hogg P J, Flaumenhaft R A substrate-driven allosteric switch that enhances PDI catalytic activity. Nature Communications 2016;  7: 12579. Full text

Berber S, Wood M, Llamosas E, Thaivalappil P, Lee K, Liao B M, Chew Y L, Rhodes A, Yucel D, Crossley M, Nicholas H R Homeodomain-interacting protein kinase (HPK-1) regulates stress responses and ageing in. Scientific Reports 2016;  6: 19582.

Blinman P, Mileshkin L, Khaw P, Goss G, Johnson C, Capp A, Brooks S, Wain G, Kolodziej I, Veillard A S, O'Connell R, Creutzberg C L, Stockler M R Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial. British Journal of Cancer 2016;  115 (10): 1179–1185.

Blumenthal N J, Byth K, Eastman C J Prevalence of thyroid dysfunction and thyroid antibodies in a private obstetrical practice in Sydney. Australian & New Zealand Journal of Obstetrics and Gynaecology 2016;  56 (3): 307–311.

Brakoulias V, Starcevic V, Belloch A, Dell'Osso L, Ferrao Y A, Fontenelle L F, Lochner C, Marazziti D, Martin A, Matsunaga H, Miguel E C, Reddy Y C, do Rosario M C, Shavitt R G, Sundar A S, Stein D J, Viswasam K International prescribing practices in obsessive-compulsive disorder (OCD). Human Psychopharmacology 2016;  31 (4): 319–324.

Brakoulias V, Starcevic V, Martin A, Berle D, Milicevic D, Viswasam K The familiality of specific symptoms of obsessive-compulsive disorder. Psychiatry Research 2016;  239: 315-319.

Brodtkorb T H, Bell M, Irving A H, Laramee P The cost effectiveness of nalmefene for reduction of alcohol consumption in alcohol-dependent patients with high or very high drinking-risk levels from a UK societal perspective. CNS Drugs 2016;  30 (2): 163-77.

Broom A, Wong W K, Kirby E, Sibbritt D, Karikios D, Harrup R, Lwin Z A qualitative study of medical oncologists' experiences of their profession and workforce sustainability. PLoS One 2016;  11 (11): e0166302. Full text

Burgess N G, Bassan M S, McLeod D, Williams S J, Byth K, Bourke M J Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors. Gut 2016;

Burgess N G, Pellise M, Nanda K S, Hourigan L F, Zanati S A, Brown G J, Singh R, Williams S J, Raftopoulos S C, Ormonde D, Moss A, Byth K, P'Ng H, McLeod D, Bourke M J Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut 2016;  65 (3): 437–446.

Bursell S E, Zang S, Keech A C, Jenkins A J Evolving telehealth reimbursement in Australia. Internal Medicine Journal 2016;  46 (8): 977–981.

Carr D, Barnes E H, Gordon A, Isaacs D Effect of antibiotic use on antimicrobial antibiotic resistance and late-onset neonatal infections over 25 years in an Australian tertiary neonatal unit. Archives of Disease in Childhood. Fetal and Neonatal Ed 2016;

Chambers S K, Foley E, Clutton S, McDowall R, Occhipinti S, Berry M, Stockler M R, Lepore S J, Frydenberg M, Gardiner R A, Davis I D, Smith D P The role of mindfulness in distress and quality of life for men with advanced prostate cancer. Quality of Life Research 2016;  25 (12): 3027–3035.

Chandrasegaram M D, Chen J W, Price T J, Zalcberg J, Sjoquist K, Merrett N D Advances in molecular pathology and treatment of periampullary cancers. Pancreas 2016;  45 (1): 32–39.

Chen A C, Martin A J, Dalziell R A, Halliday G M, Damian D L Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial (research letter). British Journal of Dermatology 2016;

Chen A C, Martin A J, Dalziell R A, McKenzie C A, Lowe P M, Eris J M, Scolyer R A, Dhillon H M, Vardy J L, Bielski V A, Halliday G M, Damian D L A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology 2016;  175 (5): 1073–1075.

Chen A C, Martin A J, Dalziell R A, McKenzie C A, Lowe P M, Eris J M, Scolyer R A, Dhillon H M, Vardy J L, Bielski V A, Halliday G M, Damian D L A phase 2 randomised controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology 2016;  175 (5): 1073–1075.

Chia N, Fulcher J, Keech A Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID. Internal Medicine Journal 2016;  46 (6): 653–662. Full text

Cho Y H, Craig M E, Januszewski A S, Benitez-Aguirre P, Hing S, Jenkins A J, Donaghue K C Higher skin autofluorescence in young people with type 1 diabetes and microvascular complications. Diabetic Medicine 2016;

Cholesterol Treatment Trialist (CTT) Collaboration,, Reith C, Blackwell L, Emberson J, Mihaylova B, Armitage J, Fulcher J, Keech A, Simes J, Baigent C, Collins R Protocol for analyses of adverse event data from randomized controlled trials of statin therapy. American Heart Journal 2016;  176: 63–69. Full text

Cholesterol Treatment Trialists' (CTT) Collaboration. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes & Endocrinology 2016;  4 (10): 829–839.

Clark W, Bird P, Gonski P, Diamond T H, Smerdely P, McNeil H P, Schlaphoff G, Bryant C, Barnes E, Gebski V Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2016;  388 (10052): 1408–1416. Full text

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith G D, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;

Damian D L, Martin A J, Scolyer R A, Chen A C, Halliday G M Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors [letter]. British Journal of Dermatology 2016;

Davis J S, Sud A, O'Sullivan M V N, Robinson J O, Ferguson P E, Foo H, van Hal S J, Ralph A P, Howden B P, Binks P M, Kirby A, Tong S Y C, Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA) study group, and for the Australasian Society for Infectious Diseases Clinical Research Network. Combination of vancomycin and beta-lactam therapy for methicillin-resistant. Clinical Infectious Diseases 2016;  62 (2): 173–180.

Dieng M, Butow PN, Costa DSJ, Morton RL, Menzies SW, Mireskandari S, Tesson S, Mann GJ, Cust AE, Kasparian NA Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. Journal of Clinical Oncology 2016;

Dieng M, Cust A E, Kasparian N A, Butow P, Costa D S, Menzies S W, Mann G J, Morton R L Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma. BMJ Open 2016;  6 (10): e012153. Full text

Dieng M, Cust A E, Kasparian N A, Mann G J, Morton R L Economic evaluations of psychosocial interventions in cancer: a systematic review. Psycho-Oncology 2016;

Donoghoe M W, Marschner I C Estimation of adjusted rate differences using additive negative binomial regression. Statistics in Medicine 2016;  35 (18): 3166–3178.

Duchesne G M, Haworth A, Bone E, Carter H, Ebert M A, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology 2016;  60 (1): 129–137.

Duchesne G M, Woo H H, Bassett J K, Bowe S J, D'Este C, Frydenberg M, King M, Ledwich L, Loblaw A, Malone S, Millar J, Milne R, Smith R G, Spry N, Stockler M, Syme R A, Tai K H, Turner S Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 TOAD ): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncology 2016;  17 (6): 727–737.

Emery J D, Jefford M, King M, Hayne D, Martin A, Doorey J, Hyatt A, Habgood E, Lim T, Hawks C, Pirotta M, Trevena L, Schofield P The ProCare trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer. BJU International 2016;

Ferraro D, Goldstein D, O'Connell R L, Zalcberg J R, Sjoquist K M, Tebbutt N C, Grimison P, McLachlan S, Lipton L L, Vasey P, Gebski V J, Aiken C, Cronk M, Ng S, Karapetis C S, Shannon J TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. Cancer Chemotherapy and Pharmacology 2016;  78 (2): 361–367.

Field K M, Rosenthal M A, Khasraw M, Sawkins K, Nowak A K Evolving management of low grade glioma: no consensus amongst treating clinicians. Journal of Clinical Neuroscience 2016;  23: 81–87.

Fisher O M, Levert-Mignon A J, Lehane C W, Botelho N K, Maag J L, Thomas M L, Edwards M, Lord S J, Bobryshev Y V, Whiteman D C, Lord R V CD151 gene and protein expression provides independent prognostic information for patients with adenocarcinoma of the esophagus and gastroesophageal junction treated by esophagectomy. Annals of Surgical Oncology 2016;

Fisher O M, Lord S J, Falkenback D, Clemons N J, Eslick G D, Lord R V The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis. Gut 2016; Full text

Fox P, Balleine R, Lee C, Gao B, Balakrishnar B, Menzies A M, Yeap S H, Ali S S, Gebski V, Provan P J, Coulter S, Liddle C, Hui R, Kefford R F, Lynch J, Wong M, Wilcken N, Gurney H Dose escalation of tamoxifen in patients with low endoxifen level: evidence for therapeutic drug monitoring: the TADE study. Clinical Cancer Research 2016;  22 (13): 3164–3171.

Gao B, Lindemann K, Anderson L, Fereday S, Hung J, Alsop K, Tothill R W, Gebski V, Kennedy C, Balleine R L, Harnett P R, Bowtell D D, DeFazio A Serous ovarian and primary peritoneal cancers: a comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. Gynecologic Oncology 2016;  142 (3): 458–464.

Garber S T, Hashimoto Y, Weathers S P, Xiu J, Gatalica Z, Verhaak R G, Zhou S, Fuller G N, Khasraw M, de Groot J, Reddy S K, Spetzler D, Heimberger A B Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro-Oncology 2016;  18 (10): 1357–1366.

Geevasinga N, Menon P, Ng K, Van Den Bos M, Byth K, Kiernan M C, Vucic S Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016; : 1-9.

Gormly K L, Coscia C, Wells T, Tebbutt N, Harvey J A, Wilson K, Schmoll H J, Price T MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Journal of Medical Imaging and Radiation Oncology 2016;  60 (5): 607–615.

Hague W E, Simes J, Kirby A, Keech A C, White H D, Hunt D, Nestel P J, Colquhoun D M, Pater H, Stewart R A, Sullivan D R, Thompson P L, West M, Glasziou P P, Tonkin A M Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: 16 years of follow-up of the LIPID Study. Circulation 2016;  133 (19): 1851–1860.

He E Y, Hawkins N J, Mak G, Roncolato F, Goldstein D, Liauw W, Clingan P, Chin M, Ward R L The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: an Australian population-based multicenter study. Oncologist 2016;  21 (5): 618-25.

Hong A, Lee C S, Jones D, Veillard A S, Zhang M, Zhang X Y, Smee R, Corry J, Porceddu S, Milross C, Elliott M, Clark J, Rose B Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades. Head and Neck 2016;  38 (5): 743–750.

Hong A, Zhang X Y, Jones D, Zhang M, Lee C S, Lyons J G, Veillard A S, Rose B E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer. Cancer Biology & Therapy 2016;  17 (2): 181–187.

Hong A, Zhang X, Jones D, Veillard A S, Zhang M, Martin A, Lyons J G, Lee C S, Rose B Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma. Radiotherapy and Oncology 2016;  118 (2): 342–349.

Hsu P, Ma A, Barnes E H, Wilson M, Hoefsloot L H, Rinne T, Munns C, Williams G, Wong M, Mehr S The immune phenotype of patients with CHARGE syndrome. Journal of Allergy and Clinical Immunology. In Practice 2016;  4 (1): 96–103 e2.

Januszewski A S, Sutanto S S, McLennan S, O'Neal D N, Keech A C, Twigg S M, Jenkins A J Shorter telomeres in adults with type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. Diabetes Research and Clinical Practice 2016;  117: 4–11.

Joglekar M V, Januszewski A S, Jenkins A J, Hardikar A A Circulating microRNA biomarkers of diabetic retinopathy. Diabetes 2016;  65 (1): 22–24. Full text

Joglekar M V, Trivedi P M, Kay T W, Hawthorne W J, O'Connell P J, Jenkins A J, Hardikar A A, Thomas H E Human islet cells are killed by BID-independent mechanisms in response to FAS ligand. Apoptosis 2016;  21 (4): 379-89.

Johnson S, Clayton J, Butow P N, Silvester W, Detering K, Hall J, Kiely B E, Cebon J, Clarke S, Bell M L, Stockler M, Beale P, Tattersall M H Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial. BMJ Open 2016;  6 (12): e012387.

Kapadia MZ, Askie L, Hartling L, Contopoulos-Ioannidis D, Bhutta ZA, Soll R, Moher D, Offringa M PRISMA-Children and PRISMA-Protocol for Children Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research. BMJ Open 2016;  6 (4) Full text

Kar P, Plummer M P, Bellomo R, Jenkins A J, Januszewski A S, Chapman M J, Jones K L, Horowitz M, Deane A M Liberal glycemic control in critically iii patients with type 2 diabetes: An exploratory study. Critical Care Medicine 2016;  44 (9): 1695–1703.

Kelly L E, Jansson L M, Moulsdale W, Pereira J, Simpson S, Guttman A, Allegaert K, Askie L, Roukema H, Lacaze T, Davis J M, Finnegan L, Williamson P, Offringa M A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi survey. Trials 2016;  17 (1): 536. Full text

Kennedy N J, Peek M J, Quinton A E, Lanzarone V, Martin A, Benzie R, Nanan R Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: a longitudinal cohort study. BJOG: International Journal of Obstetrics and Gynaecology 2016;  123 (2): 225-232.

Khalafallah A, Phuah E, Al-Barazan A M, Nikakis I, Radford A, Clarkson W, Trevett C, Brain T, Gebski V, Corbould A Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open 2016;  6 (4): e011059. Full text

Khasraw M, Ananda S, Michael M Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy. Expert Review of Anticancer Therapy 2016;  16 (4): 391–401.

Khasraw M, Lee A, McCowatt S, Kerestes Z, Buyse M E, Back M, Kichenadasse G, Ackland S, Wheeler H Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial. Journal of Neuro-Oncology 2016;  128 (1): 163-71.

Khemka A, FarajAllah C I, Lord S J, Bosley B, Al Muderis M Osseointegrated total hip replacement connected to a lower limb prosthesis: a proof-of-concept study with three cases. Journal of Orthopaedic Surgery and Research 2016;  11 (1): 13. Full text

Khemka A, Lord S J, Doyle Z, Bosley B, Al Muderis M Minimally invasive medial patellofemoral ligament reconstruction for patellar instability using an artificial ligament: A two year follow-up. Knee 2016;  23 (2): 261–266.

Kim K W, Ho A, Alshabee-Akil A, Hardikar A A, Kay T W H, Rawlinson W D, Craig M E Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets. Diabetes 2016;  65 (4): 996–1003.

Ko H In science communication, why does the idea of a public deficit always return? How do the shifting information flows in healthcare affect the deficit model of science communication?. Public Understanding of Science 2016;  25 (4): 247–432.

Ko H, Teede H, Moran L Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Research Notes 2016;  9 (1) Full text

Korczak V, Kirby A, Gunja N Chemical agents for the sedation of agitated patients in the ED: a systematic review. American Journal of Emergency Medicine 2016;

Kothur K, Wienholt L, Mohammad S S, Tantsis E M, Pillai S, Britton P N, Jones C A, Angiti R R, Barnes E H, Schlub T, Bandodkar S, Brilot F, Dale R C Utility of CSF cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis. PLoS One 2016;  11 (8): e0161656. Full text

Kwai N C G, Nigole W, Poynten A M, Brown C, Krishnan A V The relationship between dyslipidemia and acute axonal function in type 2 diabetes mellitus in vivo. Plos One 2016;  11 (4) Full text

Labra J, Menon P, Byth K, Morrison S, Vucic S Rate of disease progression: a prognostic biomarker in ALS. Journal of Neurology, Neurosurgery and Psychiatry 2016;  87 (6): 628-32.

Laramee P, Bell M, Irving A, Brodtkorb T H The cost-effectiveness of the integration of nalmefene within the uk healthcare system treatment pathway for alcohol dependence. Alcohol Alcohol 2016;  51 (3): 283–290.

Lawrence N J, Salkeld G, Stockler M R, Karikios D Valuing the benefits of new anticancer drugs. Medical Journal of Australia 2016;  204 (11): 403–405. Full text

Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D, Gebski V, Friedlander M, Yeung A, Wong N, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong S, Lewis C, Vasey P, Grimison P Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group [letter]. Annals of Oncology 2016;

Lee C K, Davies L, Gebski V J, Lord S J, Di Leo A, Johnston S, Geyer C Jr, Cameron D, Press M F, Ellis C, Loi S, Marschner I, Simes J, de Souza P Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer. Journal of Clinical Oncology 2016;  34 (9): 936–944.

Lee C K, Man J, Lord S, Links M, Gebski V, Mok T, Yang J C Brief report: Checkpoint inhibitors in metastatic EGFR mutated non-small-cell lung cancer—a meta-analysis. Journal of Thoracic Oncology 2016;

Lee Chee Khoon, Man Johnathan, Lord Sally, Links Matthew, Gebski Val, Mok Tony, Yang James Chih-Hsin. Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer—a meta-analysis. Journal of Thoracic Oncology 2016;

Lee E, Campbell D E, Barnes E H, Mehr S S Resolution of acute food protein-induced enterocolitis syndrome in children. Journal of Allergy and Clinical Immunology. In Practice 2016;

Lester A, Rapkins R, Nixdorf S, Khasraw M, McDonald K Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?. Clinical and Translational Oncology 2016;

Leung M, Wong V W, Hudson M, Leung D Y Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus. Circulation Cardiovascular Imaging 2016;  9 (3): e003643.

Li J J, Wittert G A, Vincent A, Atlantis E, Shi Z, Appleton S L, Hill C L, Jenkins A J, Januszewski A S, Adams R J Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism 2016;  65 (6): 883–892.

Lieng H, Gebski V J, Morgan G J, Veness M J Important prognostic significance of lymph node density in patients with node positive oral tongue cancer. ANZ Journal of Surgery 2016;  86 (9): 681–686.

Lindemann K, Halaska M J, Zalewski K, LIFE Team. Surgical treatment of primary ovarian fallopian tube and peritoneal cancer. International Journal of Gynecological Cancer 2016;  26 (Suppl. 1): 5–6.

Lindemann K, Kristensen G, Mirza M R, Davies L, Hilpert F, Romero I, Ayhan A, Burges A, Rubio M J, Raspagliesi F, Huizing M, Creemers G J, Lykka M, Lee C K, Gebski V, Pujade-Lauraine E Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial. Annals of Oncology 2016;  27 (8): 1505–1510.

Lindemann K, Zalewski K, Halaska M J, LIFE Team. Preface. International Journal of Gynecological Cancer 2016;  26 (Suppl. 1): 2.

Liu G, Tu D, Lewis M, Cheng D, Sullivan L A, Chen Z, Morgen E, Simes J, Price T J, Tebbutt N C, Shapiro J D, Jeffery G M, Mellor J D, Mikeska T, Virk S, Shepherd L E, Jonker D J, O'Callaghan C J, Zalcberg J R, Karapetis C S, Dobrovic A Fc-gamma receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer. Clinical Cancer Research 2016;  22 (10): 2435–2444.

Luckett T, Spencer L, Morton R L, Pollock C A, Lam L, Silvester W, Sellars M, Detering K M, Butow P N, Tong A, Clayton J M Advance care planning in chronic kidney disease: a survey of current practice in Australia. Nephrology (Carlton) 2016;

Luke J N, Ritte R, O'Dea K, Brown A, Piers L S, Jenkins A J, Rowley K G Nutritional predictors of successful chronic disease prevention for a community cohort in Central Australia. Public Health Nutrition 2016;  19 (13): 2475–2483.

Luke J N, Schmidt D F, Ritte R, O'Dea K, Brown A, Piers L S, Jenkins A J, Rowley K G Nutritional predictors of chronic disease in a Central Australian Aboriginal cohort: a multi-mixture modelling analysis. Nutrition, metabolism, and cardiovascular diseases 2016;  26 (2): 162-8.

Madronio C M, Armstrong B K, Watts C G, Goumas C, Morton R L, Curtin A, Menzies S W, Mann G J, Thompson J F, Cust A E Doctors' recognition and management of melanoma patients' risk: An Australian population-based study. Cancer Epidemiology 2016;  45: 32–39.

Manski-Nankervis J, Yates C J, Blackberry I, Furler J, Ginnivan L, Cohen N, Jenkins A, Vasanthakumar S, Gorelik A, Young D, Best J, O'Neal D Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study. Diabetic Medicine 2016;  33 (6): 803-11.

Martyn J, Roncolato F, Willson M L, Lindemann K, Mileshkin L PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Database of Systematic Reviews 2016;  2016 (4): CD012160. Full text

McAuley S A, Dang T T, Horsburgh J C, Bansal A, Ward G M, Aroyan S, Jenkins A J, MacIsaac R J, Shah R V, O'Neal D N Feasibility of an orthogonal redundant sensor incorporating optical plus redundant electrochemical glucose sensing. Journal of Diabetes Science and Technology 2016;  10 (3): 679–688.

McAuley S A, Horsburgh J C, Ward G M, La Gerche A, Gooley J L, Jenkins A J, MacIsaac R J, O'Neal D N Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia 2016;  59 (8): 1636–1644.

McCombie S, Chang D, Sengupta S, Stockler M, Davis I, Hayne D Moving toward an evidence and consensus based multi-centre enhanced recovery pathway for radical cystectomy: results of an ANZUP survey. BJU International 2016;  117: 98–99.

McKinlay C J, Rebello C, Tarnow-Mordi W Probiotics in very preterm infants: the PiPS trial. Lancet 2016;  388 (10045): 655.

Meher S, Duley L, Hunter K, Askie L Antiplatelet therapy before or after 16 weeks gestation for preventing preeclampsia: an individual participant data meta-analysis. American Journal of Obstetrics and Gynecology 2016;

Melloh M, Staub L P, Lord S J, Barz T Letter to the editor concerning "Relationship between sedimentation sign and morphological grade in symptomatic lumbar spinal stenosis" (by Laudato PA, Kulik G, Schizas C (2015) Eur Spine J; 24(10):2264-2268). European Spine Journal 2016;  25 (11): 3768–3769.

Mercieca-Bebber R, Friedlander M, Kok P S, Calvert M, Kyte D, Stockler M, King M T The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols. Quality of Life Research 2016;  25 (10): 2457–2465.

Mercieca-Bebber R, Palmer M J, Brundage M, Calvert M, Stockler M R, King M T Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review. BMJ Open 2016;  6 (6): e010938. Full text

Merom D, Mathieu E, Cerin E, Morton R L, Simpson J M, Rissel C, Anstey K J, Sherrington C, Lord S R, Cumming R G Social dancing and incidence of falls in older adults: A cluster randomised controlled trial. PLoS Med 2016;  13 (8): e1002112. Full text

Mohammad S S, Soe S M, Pillai S C, Nosadini M, Barnes E H, Gill D, Dale R C Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis. Clinical Neurophysiology 2016;  127 (10): 3217–3224.

Monaghan P J, Lord S J, John A S, Sandberg S, Cobbaert C M, Lennartz L, Verhagen-Kamerbeek W D, Ebert C, Bossuyt P M, Horvath A R Biomarker development targeting unmet clinical needs. Clinical Chimica Acta 2016;  460: 211–219.

Morton R Do dialysis decision aids improve treatment decision-making?. Peritoneal Dialysis International 2016;  36 (4): 359–361.

Morton R L, Kurella Tamura M, Coast J, Davison S N Supportive care: economic considerations in advanced kidney disease. Clinical Journal of the American Society of Nephrology 2016;

Morton R L, Schlackow I, Mihaylova B, Staplin N D, Gray A, Cass A The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review. Nephrology, Dialysis, Transplantation 2016;  31 (1): 46–56.

Morton R L, Webster A C, McGeechan K, Howard K, Murtagh F E, Gray N A, Kerr P G, Germain M J, Snelling P Conservative management and end of life care in an Australian cohort with ESRD. Clinical Journal of the American Society of Nephrology 2016;

Moth E, McLachlan SA, Veillard AS, Muljadi N, Hudson M, Stockler MR, Blinman P Patients’ preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer. Lung Cancer 2016;  95 (May): 8–14.

Mullins R J, Wainstein B K, Barnes E H, Liew W K, Campbell D E Increases in anaphylaxis fatalities in Australia 1997 to 2013. Clinical and Experimental Allergy 2016;  46 (8): 1099–1110.

Murtagh F E, Burns A, Moranne O, Morton R L, Naicker S Supportive care: comprehensive conservative care in end-stage kidney disease. Clinical Journal of the American Society of Nephrology 2016;

Naranjo-Ortiz C, Shek K L, Martin A J, Dietz H P What is normal bladder neck anatomy?. International Urogynecology Journal and Pelvic Floor Dysfunction 2016;  27 (6): 945–950.

Neale R E, Armstrong B K, Baxter C, Romero B D, Ebeling P, English D R, Kimlin M G, McLeod D S, O Connell RL, van der Pols J C, Venn A J, Webb P M, Whiteman D C, Wockner L The D-Health Trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemporary Clinical Trials 2016;  48: 83–90.

Noonan J E, Ward G M, Sarossy M, Man R E, Nguyen T T, Jenkins A J, Dusting G J, Lamoureux E L Retinal neuronal and vascular function in type 1 diabetes adults during glycaemic clamps. Clinical and Experimental Pharmacology & Physiology 2016;  43 (3): 382-4.

O'Brien C L, Ski C F, Thompson D R, Moore G, Mancuso S, Jenkins A, Ward G, MacIsaac R J, Loh M, Knowles S R, Rossell S L, Castle D J The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial. Trials 2016;  17 (1): 444. Full text

Oei J L, Ghadge A, Coates E, Wright I M, Saugstad O D, Vento M, Buonocore G, Nagashima T, Suzuki K, Hosono S, Davis P G, Craven P, Askie L, Dawson J, Garg S, Keech A, Rabi Y, Smyth J, Sinha S, Stenson B, Lui K, Hunter C L, Tarnow Mordi W Clinicians in 25 countries prefer to use lower levels of oxygen to resuscitate preterm infants at birth. Acta Paediatrica  2016;  105 (9): 1061–1066.

Ogle G D, Abdullah M, Mason D, Januszewski A S, Besancon S Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabetic Medicine 2016;  33 (11): 1544–1553.

Ogle G D, Kim H, Middlehurst A C, Silink M, Jenkins A J Financial costs for families of children with type 1 diabetes in lower-income countries. Diabetic Medicine 2016;  33 (6): 820–826.

Parkinson L, Moorin R, Peeters G, Byles J, Blyth F, Caughey G, Cunich M, Magin P, March L, Pond D Incident osteoarthritis associated with increased allied health services use in 'baby boomer' Australian women. Australian and New Zealand Journal of Public Health 2016;  40 (4): 356–361.

Pavlakis N, Sjoquist K M, Martin A J, Tsobanis E, Yip S, Kang Y K, Bang Y J, Alcindor T, O'Callaghan C J, Burnell M J, Tebbutt N C, Rha S Y, Lee J, Cho J Y, Lipton L R, Wong M, Strickland A, Kim J W, Zalcberg J R, Simes J, Goldstein D Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): a multinational placebo-controlled phase II trial. Journal of Clinical Oncology 2016;  34 (23): 2728–2735.

Pellise M, Burgess N G, Tutticci N, Hourigan L F, Zanati S A, Brown G J, Singh R, Williams S J, Raftopoulos S C, Ormonde D, Moss A, Byth K, P'Ng H, Mahajan H, McLeod D, Bourke M J Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions. Gut 2016;

Pham Trang T, Ward Rachel, Latty Drew, Owen Catherine, Gebski Val, Chojnowski Jacek, Kelly Christopher, Ahern Verity, Tiver Kenneth, Stuart Kirsty, Wang Wei. Left-sided breast cancer loco-regional radiotherapy with deep inspiration breath-hold: Does volumetric-modulated arc radiotherapy reduce heart dose further compared with tangential intensity-modulated radiotherapy?. Journal of Medical Imaging and Radiation Oncology 2016;  60 (4): 545–553.

Phillips C, Jeffree R, Khasraw M Management of breast cancer brain metastases: a practical review. Breast 2016;  31: 90–98.

Pickering H, Murray J, Lin C S, Cormack C, Martin A, Kiernan M C, Krishnan A V Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trial. Clin Neurophysiol 2016;  128 (1): 93–99.

Pillai S C, Mohammad S S, Hacohen Y, Tantsis E, Prelog K, Barnes E H, Gill D, Lim M J, Brilot F, Vincent A, Dale R C Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia 2016;  57 (1): E7–E11.

Popat H, Robledo KP, Sebastian L, Evans N, Gill A, Kluckow M, Sinhal S, de Waal K, Tarnow-Mordi W, Osborn D Effect of delayed cord clamping on systemic blood flow: a randomized controlled trial. Journal of Pediatrics 2016;  178: 81–86.e2.

Price T J, Thavaneswaran S, Burge M, Segelov E, Haller D G, Punt C J, Arnold D, Karapetis C S, Tebbutt N C, Pavlakis N, Gibbs P, Shapiro J D Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015. Expert Review of Anticancer Therapy 2016;  16 (5): 557–571.

Ralph AP, Read C, Johnston V, de Dassel JL, Bycroft K, Mitchell A, Bailie RS, Maguire GP, Edwards K, Currie BJ, Kirby A, Carapetis JR. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial. Trials 2016;  17: 51. Full text

Ritte R, Luke J, Nelson C, Brown A, O'Dea K, Jenkins A, Best J D, McDermott R, Daniel M, Rowley K Clinical outcomes associated with albuminuria in central Australia: a cohort study. BMC Nephrology 2016;  17 (1): 113. Full text

Roncolato F T, Chatfield M, Houghton B, Toner G, Stockler M, Thomson D, Friedlander M, Gurney H, Rosenthal M, Grimison P The effect of pulmonary function testing on bleomycin dosing in germ cell tumours. Internal Medicine Journal 2016;  46 (8): 893–898.

Sabatine MS, Giugliano RP, Keech A, Honarpour N, Wang H, Liu T, Wasserman S M, Scott R, Sever PS, Pedersen TR Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial. American Heart Journal 2016;  173: 94–101.

Schofield PE, Stockler M R, Zannino D, Tebbutt N C, Price T J, Simes R J, Wong N, Pavlakis N, Ransom D, Moylan E, Underhill C, Wyld D, Burns I, Ward R, Wilcken N, Jefford M Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer 2016;  24 (1): 401–408.

Schou I M, Marschner I C Design of clinical trials involving multiple hypothesis tests with a common control. Biometrical Journal 2016;

Scott AM Health technology assessment in Australia: a role for clinical registries?. Australian Health Review 2016;

Segelov E, Thavaneswaran S, Waring PM, Desai J, Robledo KP, Gebski VJ, Elez E, Nott LM, Karapetis CS, Lunke S, Chantrill LA, Pavlakis N, Khasraw M, Underhill C, Ciardiello F, Jefford M, Wasan H, Haydon A, Price TJ, van Hazel G, Wilson K, Simes J, Shapiro JD Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian Gastro-Intestinal Trials Group ICECREAM study. Journal of Clinical Oncology 2016;  34 (9): 2258–2264.

Segelov E, Waring P, Desai J, Wilson K, Gebski V, Thavaneswaran S, Elez E, Underhill C, Pavlakis N, Chantrill L, Nott L, Jefford M, Khasraw M, Day F, Wasan H, Ciardiello F, Karapetis C, Joubert W, van Hazel G, Haydon A, Price T, Tejpar S, Tebbutt N, Shapiro J ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours. BMC Cancer 2016;  16: 339. Full text

Sharifi A, De Bock M I, Jayawardene D, Loh M M, Horsburgh J C, Berthold C L, Paramalingam N, Bach L A, Colman P G, Davis E A, Grosman B, Hendrieckx C, Jenkins A J, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac R J, Speight J, Trawley S, Ward G M, Roy A, Jones T W, O'Neal D N Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technology & Therapeutics 2016;

Shetty A L, Vaghasiya M, Boddy R, Byth K, Unwin D Perceived incivility during emergency department phone consultations. Emergency Medicine Australasia 2016;  28 (3): 256–261.

Single A N V, Scott A M, Wale J Developing guidance on ethics for patient groups collecting and reporting patient information for health technology assessments. Patient 2016;  9 (1): 1–4.

Skjodt M K, Abdullah M, Mason D, Januszewski A S, Besancon S, Ogle G D Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabetic Medicine 2016;  33 (11): 1544–1553.

Smit AK, Espinoza D, Newson AJ, Morton RL, Fenton G, Freeman L, Dunlop K, Butow PN, Law MH, Kimlin MG, Keogh LA, Dobbinson SJ, Kirk J, Kanetsky PA, Mann GJ, Cust AE A pilot randomised controlled trial of the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to the public. Cancer Epidemiology Biomarkers & Prevention 2016;

Smith A, Butow P, Olver I, Luckett T, Grimison P, Toner G C, Stockler M R, Hovey E, Stubbs J, Turner S, Hruby G, Gurney H, Alam M, Cox K, King M T The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. Journal of Cancer Survivorship 2016;  10 (2): 223–233.

Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, Garcia Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Luck H J, Gonzalez-Martin A, Kristensen G, Levache C B, Lee C K, Gebski V, Pujade-Lauraine E Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: subgroup analysis of the randomised phase III AURELIA trial. Gynecologic Oncology 2016;

Stern K, Cho Y H, Benitez-Aguirre P, Jenkins A J, McGill M, Mitchell P, Keech A C, Donaghue K C QT interval, corrected for heart rate, is associated with HbA concentration and autonomic function in diabetes. Diabetic Medicine 2016;  33 (10): 1415–1421.

Stitt A W, Curtis T M, Chen M, Medina R J, McKay G J, Jenkins A, Gardiner T A, Lyons T J, Hammes H P, Simo R, Lois N The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research 2016;  51: 156-86.

Sundaresan P, Milross C G, Stockler M R, Costa D S, King M T Phase 1 in the development of a patient-reported measure to quantify perceived inconvenience of radiotherapy: generation of issues. Quality of Life Research 2016;  25 (9): 2361–2366.

Sundaresan P, Stockler M R, Milross C G What is access to radiation therapy? A conceptual framework and review of influencing factors. Australian Health Review 2016;  40 (1): 11–18.

Tan J W, Valerio C, Barnes E H, Turner P J, Van Asperen P A, Kakakios A M, Campbell D E A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy. Journal of Allergy and Clinical Immunology 2016; Full text

Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E, Donoghoe M, Deshpande S, Morley C, King A, Doyle LW, Fleck BW, Davis P, Halliday HL, Hague W, Cairns P, Darlow BA, Fielder AR, Gebski V, Marlow N, Simmer K, Tin W, Ghadge A, Williams C, Keech A, Wardle SP, Kecskes Z, Kluckow M, Gole G, Evans N, Malcolm G, Luig M, Wright I, Stack J, Tan K, Pritchard M, Gray PH, Morris S, Headley B, Dargaville P, Simes RJ, Brocklehurst P Outcomes of two trials of oxygen-saturation targets in preterm infants. New England Journal of Medicine 2016;  374 (8): 749–760. Full text

Tebbutt N C, Price T J, Ferraro D A, Wong N, Veillard A S, Hall M, Sjoquist K M, Pavlakis N, Strickland A, Varma S C, Cooray P, Young R, Underhill C, Shannon J A, Ganju V, Gebski V Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial. British Journal of Cancer 2016;  114 (5): 505-9.

Thavaneswaran S, Price T J Optimal therapy for resectable rectal cancer. Expert Review of Anticancer Therapy 2016;  16 (3): 285–302.

Tong A, Morton R L, Webster A C How qualitative research informs clinical and policy decision making in transplantation: a review. Transplantation 2016;  100 (9): 1997–2005.

Traill C L, Januszewski A S, Larkins R G, Keech A C, Jenkins A J Time to research Australian female physician-researchers. Internal Medicine Journal 2016;  46 (4): 412–419.

Traill C L, Januszewski A S, Larkins R, Keech A C, Jenkins A J Time to research Australian physician researchers. Internal Medicine Journal 2016;  46 (5): 550–558.

Tseros E A, Gebski V, Morgan G J, Veness M J Prognostic significance of lymph node ratio in metastatic cutaneous squamous cell carcinoma of the head and neck. Annals of Surgical Oncology 2016;  23 (5): 1693-8.

Tully P J, Baumeister H, Martin S, Atlantis E, Jenkins A, Januszewski A, O'Loughlin P, Taylor A, Wittert G A, Florey Adelaide Male Ageing Study. Elucidating the biological mechanisms linking depressive symptoms with type 2 diabetes in men: the longitudinal effects of inflammation, microvascular dysfunction, and testosterone. Psychosomatic Medicine 2016;  78 (2): 221–232.

Turner S, Sundaresan P, Mann K, Pryor D, Gebski V, Shaw T Engaging future clinical oncology researchers: an initiative to integrate teaching of biostatistics and research methodology into specialty training. Clinical Oncology (Royal College of Radiologists) 2016;  28 (5): 306-16.

van Hazel G A, Heinemann V, Sharma N K, Findlay M P, Ricke J, Peeters M, Perez D, Robinson B A, Strickland A H, Ferguson T, Rodrigez J, Kroning H, Wolf I, Ganju V, Walpole E, Boucher E, Tichler T, Shacham-Shmueli E, Powell A, Eliadis P, Isaacs R, Price D, Moeslein F, Taieb J, Bower G, Gebski V, Van Buskirk M, Cade D N, Thurston K, Gibbs P SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology 2016;  34 (15): 1723–1731.

Vasista A, Stockler M R, West T, Wilcken N, Kiely B E More than just the median: calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials. Breast 2016;  31: 99–104.

Vernooij R W, Willson M, Gagliardi A R Characterizing patient-oriented tools that could be packaged with guidelines to promote self-management and guideline adoption: a meta-review. Implementation Science 2016;  11 (1): 52. Full text

Vickers M M, Lee C, Tu D, Wheatley-Price P, Parulekar W, Brundage M D, Moore M J, Au H, O'Callaghan C J, Jonker D J, Ringash J, Goldstein D Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3. Pancreatology 2016;  16 (6): 1106-1112.

Walker R C, Howard K, Morton R L Patient education and choice of peritoneal dialysis. American Journal of Kidney Diseases 2016;  68 (3): 341–343.

Walker R C, Howard K, Tong A, Palmer S C, Marshall M R, Morton R L The economic considerations of patients and caregivers in choice of dialysis modality. Hemodialysis International 2016;  20 (4): 634–642.

Walker R, Marshall R, Howard K, Morton R L, Marshall M R "Who matters most?": clinician perspectives of influence and recommendation on home dialysis uptake. Nephrology (Carlton) 2016;

Walker Rachael C, Howard Kirsten, Morton Rachael L, Palmer Suetonia C, Marshall Mark R, Tong Allison. Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study. Nephrology Dialysis Transplantation 2016;  31 (1): 133–141. Full text

Wann A, Ashley D, Khasraw M Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre. Supportive Care in Cancer 2016;  24 (7): 3023–3028.

Watts C G, Madronio C M, Morton R L, Goumas C, Armstrong B K, Curtin A, Menzies S W, Mann G J, Thompson J F, Cust A E Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: a population-based study in New South Wales, Australia. Australasian Journal of Dermatology 2016;

Watts C G, Madronio C, Morton R L, Goumas C, Armstrong B K, Curtin A, Menzies S W, Mann G J, Thompson J F, Cust A E Clinical features associated with individuals at higher risk of melanoma: A population-based study. JAMA Dermatology 2016;

Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma. Journal of Clinical Oncology 2016;

Webster A C, Nagler E V, Morton R L, Masson P Chronic kidney disease. Lancet 2016;

Williams K H, Sullivan D R, Nicholson G C, George J, Jenkins A J, Januszewski A S, Gebski V J, Manning P, Tan Y M, Donoghoe M W, Ehnholm C, Young S, O'Brien R, Buizen L, Twigg S M, Keech A C Opposite associations between alanine aminotransferase and gamma-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism 2016;  65 (5): 783-793.

Williams K H, Sullivan D R, Veillard A S, O'Brien R, George J, Jenkins A J, Young S, Ehnholm C, Duffield A, Twigg S M, Keech A C Low alanine aminotransferase levels and higher number of cardiovascular events in people with type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetic Medicine 2016;  33 (3): 356–364.

Wye D, Woo J, Mein B, Magotti R, Martin A, Benzie R Transperineal use of a pocket-sized ultrasound machine versus conventional transvaginal ultrasound: A blinded comparison of cervical length in pregnancy. Ultrasound in Obstetrics and Gynecology 2016;  48 (4): 535–536.

Wyld M L, Chadban S J, Morton R L Improving our understanding of quality of life in CKD. American Journal of Kidney Diseases 2016;  67 (6): 820–821.

Zalewski K, Lindemann K, Halaska M J, LIFE Team. Medical treatment of primary ovarian cancer. International Journal of Gynecological Cancer 2016;  26 (Suppl. 1): 9–10.

Zalewski K, Lindemann K, Halaska M J, LIFE Team.  Medical treatment of recurrent ovarian cancer. International Journal of Gynecological Cancer 2016;  26 (Suppl. 1): 11.

Zdenkowski N, Forbes JF, Boyle FM, Kannourakis G, Gill P G, Bayliss E, Saunders C, Della-Fiorentina S, Kling N, Campbell I, Mann GB, Coates AS, Gebski V, Davies L, Thornton R, Reaby L, Cuzick J, Green M Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor positive breast cancer (ANZ0501 LATER): an open-label randomised controlled trial. Annals of Oncology 2016;  27 (5): 806–812.

Zhang Y, Jenkins A J, Basu A, Stoner J A, Lopes-Virella M F, Klein R L, Cleary P A, Lyons T J Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. Journal of Lipid Research 2016;  57 (2): 310–317. Full text